Wellington Management Group’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-75,658
Closed -$411K 2109
2025
Q2
$411K Buy
+75,658
New +$377K ﹤0.01% 1846
2025
Q1
Sell
-83,392
Closed -$858K 2050
2024
Q4
$858K Buy
83,392
+6,022
+8% +$75K ﹤0.01% 1744
2024
Q3
$1.05M Sell
77,370
-13,543
-15% -$168K ﹤0.01% 1703
2024
Q2
$1.18M Buy
90,913
+6,703
+8% +$82.9K ﹤0.01% 1634
2024
Q1
$795K Buy
+84,210
New +$819K ﹤0.01% 1731
2023
Q2
Sell
-312,855
Closed -$1.29M 2001
2023
Q1
$1.29M Sell
312,855
-27,605
-8% -$117K ﹤0.01% 1592
2022
Q4
$1.46M Sell
340,460
-828,094
-71% -$13.9M ﹤0.01% 1570
2022
Q3
$22.2M Buy
+1,168,554
New +$21.1M ﹤0.01% 881

Other funds holding THRD

Wellington Management Group's THRD Position: Q3 2025 in Review

Wellington Management Group sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 75,658 shares — an estimated $411K sold.

Wellington Management Group first reported a position in THRD in Q3 2022 and held it in 8 quarters. The position peaked at $22.2M in Q3 2022. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Wellington Management Group reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Wellington Management Group sold 75,658 Third Harmonic Bio shares in Q3 2025, an estimated $411K.
  • Wellington Management Group first reported a position in Third Harmonic Bio in Q3 2022 and held it in 8 quarters.
  • Wellington Management Group's Third Harmonic Bio position peaked at $22.2M in Q3 2022.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Wellington Management Group's 13F filing for Q3 2025, filed 14 Nov 2025.